Celltrion Pharm, Inc. (KOSDAQ: 068760)

Celltrion Pharm Revenue

Celltrion Pharm had revenue of 85.55B KRW in the quarter ending March 31, 2021, with 92.73% growth. This brings the company's revenue in the last twelve months to 274.73B, up 53.21% year-over-year. In the year 2020, Celltrion Pharm had annual revenue of 233.57B with 34.61% growth.

• Revenue (ttm): 274.73B
• Revenue Growth: +53.21%
• P/S Ratio: 9.02
• Revenue / Employee: 837.59M
• Employees: 328
• Market Cap: 2,477.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2020	233.57B	60.06B	34.61%
Dec 31, 2019	173.51B	26.63B	18.13%
Dec 31, 2018	146.88B	11.02B	8.11%
Dec 31, 2017	135.86B	31.05B	29.62%
Dec 31, 2016	104.81B	30.08B	40.25%